TY - JOUR
T1 - The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study
AU - Petersen, Esben Thade
AU - Mouridsen, Kim
AU - Golay, Xavier
AU - Larsson, Henrik Bo Wiberg
AU - Hansen, Adam Espe
AU - all named co-authors of the QUASAR test-retest study
PY - 2010/1/1
Y1 - 2010/1/1
N2 - Arterial Spin Labeling (ASL) is a method to measure perfusion using magnetically labeled blood water as an endogenous tracer. Being fully non-invasive, this technique is attractive for longitudinal studies of cerebral blood flow in healthy and diseased individuals, or as a surrogate marker of metabolism. So far, ASL has been restricted mostly to specialist centers due to a generally low SNR of the method and potential issues with user-dependent analysis needed to obtain quantitative measurement of cerebral blood flow (CBF). Here, we evaluated a particular implementation of ASL (called Quantitative STAR labeling of Arterial Regions or QUASAR), a method providing user independent quantification of CBF in a large test-retest study across sites from around the world, dubbed "The QUASAR reproducibility study". Altogether, 28 sites located in Asia, Europe and North America participated and a total of 284 healthy volunteers were scanned. Minimal operator dependence was assured by using an automatic planning tool and its accuracy and potential usefulness in multi-center trials was evaluated as well. Accurate repositioning between sessions was achieved with the automatic planning tool showing mean displacements of 1.87 ± 0.95 mm and rotations of 1.56 ± 0.66°. Mean gray matter CBF was 47.4 ± 7.5 [ml/100 g/min] with a between-subject standard variation SDb = 5.5 [ml/100 g/min] and a within-subject standard deviation SDw = 4.7 [ml/100 g/min]. The corresponding repeatability was 13.0 [ml/100 g/min] and was found to be within the range of previous studies.
AB - Arterial Spin Labeling (ASL) is a method to measure perfusion using magnetically labeled blood water as an endogenous tracer. Being fully non-invasive, this technique is attractive for longitudinal studies of cerebral blood flow in healthy and diseased individuals, or as a surrogate marker of metabolism. So far, ASL has been restricted mostly to specialist centers due to a generally low SNR of the method and potential issues with user-dependent analysis needed to obtain quantitative measurement of cerebral blood flow (CBF). Here, we evaluated a particular implementation of ASL (called Quantitative STAR labeling of Arterial Regions or QUASAR), a method providing user independent quantification of CBF in a large test-retest study across sites from around the world, dubbed "The QUASAR reproducibility study". Altogether, 28 sites located in Asia, Europe and North America participated and a total of 284 healthy volunteers were scanned. Minimal operator dependence was assured by using an automatic planning tool and its accuracy and potential usefulness in multi-center trials was evaluated as well. Accurate repositioning between sessions was achieved with the automatic planning tool showing mean displacements of 1.87 ± 0.95 mm and rotations of 1.56 ± 0.66°. Mean gray matter CBF was 47.4 ± 7.5 [ml/100 g/min] with a between-subject standard variation SDb = 5.5 [ml/100 g/min] and a within-subject standard deviation SDw = 4.7 [ml/100 g/min]. The corresponding repeatability was 13.0 [ml/100 g/min] and was found to be within the range of previous studies.
U2 - http://dx.doi.org/10.1016/j.neuroimage.2009.07.068
DO - http://dx.doi.org/10.1016/j.neuroimage.2009.07.068
M3 - Journal article
SN - 1053-8119
VL - 49
SP - 104
EP - 113
JO - NeuroImage
JF - NeuroImage
IS - 1
ER -